Show simple item record

dc.contributor.authorPage, R
dc.contributor.authorShankar, Rohit
dc.contributor.authorMcLean, BN
dc.contributor.authorHanna, J
dc.contributor.authorNewman, Craig
dc.date.accessioned2018-03-15T13:09:02Z
dc.date.available2018-03-15T13:09:02Z
dc.date.issued2018-03-02
dc.identifier.issn1664-2295
dc.identifier.issn1664-2295
dc.identifier.otherARTN 99
dc.identifier.urihttp://hdl.handle.net/10026.1/11092
dc.description.abstract

Epilepsy is associated with a significant increase in morbidity and mortality. The likelihood is significantly greater for those patients with specific risk factors. Identifying those at greatest risk of injury and providing expert management from the earliest opportunity is made more challenging by the circumstances in which many such patients present. Despite increasing recognition of the importance of earlier identification of those at risk, there is little or no improvement in outcomes over more than 30 years. Despite ever increasing sophistication of drug development and delivery, there has been no meaningful improvement in 1-year seizure freedom rates over this time. However, in the last few years, there has been an increase in patient-triggered interventions based on automated monitoring of indicators and risk factors facilitated by technological advances. The opportunities such approaches provide will only be realized if accompanied by current working practice changes. Replacing traditional follow-up appointments at arbitrary intervals with dynamic interventions, remotely and at the point and place of need provides a better chance of a substantial reduction in seizures for people with epilepsy. Properly implemented, electronic platforms can offer new opportunities to provide expert advice and management from first presentation thus improving outcomes. This perspective paper provides and proposes an informed critical opinion built on current evidence base of an outline techno-therapeutic approach to harnesses these technologies. This conceptual framework is generic, rather than tied to a specific product or solution, and the same generalized approach could be beneficially applied to other long-term conditions.

dc.format.extent99-
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.language.isoeng
dc.publisherFrontiers Media SA
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectepilepsy technology
dc.subjectautomated epilepsy risk monitoring
dc.subjectelectronic health platforms
dc.subjectmobile apps
dc.subjectEpilepsy Self-Monitor
dc.subjectself-empowerment
dc.subjectco-production of health records
dc.titleDigital Care in Epilepsy: A Conceptual Framework for Technological Therapies
dc.typejournal-article
dc.typeJournal Article
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000426732400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issueMAR
plymouth.volume9
plymouth.publication-statusPublished online
plymouth.journalFrontiers in Neurology
dc.identifier.doi10.3389/fneur.2018.00099
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Health and Community
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CCT&PS
plymouth.organisational-group/Plymouth/Users by role
dc.publisher.placeSwitzerland
dcterms.dateAccepted2018-02-12
dc.rights.embargodate2024-01-04
dc.identifier.eissn1664-2295
rioxxterms.versionofrecord10.3389/fneur.2018.00099
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
rioxxterms.licenseref.startdate2018
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International

All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV